Arlington County, in partnership with Virginia Hospital Center and the Arlington Free Clinic, will open its first walk-up COVID-19 sample collection site at the Arlington Mill Community Center, 909 South Dinwiddie Street.
“Arlington is committed to assuring everyone in our community has access to the testing they need during this pandemic,” said Dr. Reuben Varghese, Arlington Public Health Director. “This is an important partnership that will help our more vulnerable or low-income groups who do not have access to cars to walk up and get tested.”
“This is an exciting effort to create a more equitable testing model for everyone who needs it,” said Nancy White, Executive Director, Arlington Free Clinic. “This model aligns with our mission to provide high-quality health care to low-income, uninsured Arlington residents through the generosity of donors and volunteers.”
“Virginia Hospital Center is happy to lend the expertise we have gathered from the North Quincy drive-through site to support the efforts at Arlington Mill,” said James Meenan, Director of the VHC Outpatient Lab. “Our primary focus is always the health and safety of our community and increasing access to testing is a critical step forward in combatting the COVID-19 pandemic.”
- The clinic opens Tuesday, May 12 and will operate weekdays between 1-5 p.m.
- To be tested, patients must obtain a clinician referral and then schedule an appointment by calling 703-558-5766. Patients must schedule an appointment before visiting the collection site.
- Residents without health insurance can still access testing through the walk-up collection site by calling the appointment number for a medical consultation and a referral for testing.
- Individuals who visit the collection site should follow the instructions of their health care provider and self-isolate while they await their results.
- Patients with an appointment may access the clinic at Arlington Mill Community Center by entering through the outdoor plaza facing Columbia Pike.
- Individuals must bring proof of identity (U.S. government ID not required).
To protect patient privacy, media access to the site will be restricted. A scheduled media briefing will occur on May 12. A separate media advisory with details will be sent.